Michelle spent 4 years in the pharmaceutical Industry as a regulatory/investigative toxicologist, then joined the MHRA and is now a Senior Pharmaco-Toxicologist. Principally, this involves the assessment of nonclinical data for Clinical Trials and Marketing Authorisation applications and the provision of regulatory/scientific advice to stakeholders for both the MHRA and the EU’s Committee for Human Medicinal Products (CHMP). She is also a UK accredited expert supporting CHMP.